RHL Group’s Abbott ABT Stock Holding History

RHL Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Buy	2,520 +16	+0.6%	+$1.46K	0.19%	30
2026 Q1	$257K	Buy	2,504 +314	+14%	+$35.5K	0.22%	28
2025 Q4	$274K	Buy	+2,190	New	+$279K	0.22%	28

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

RHL Group's ABT Position: Q2 2026 in Review

RHL Group increased its Abbott (ABT) stake by 0.64% in Q2 2026, buying an estimated $1.46K and bringing the position to 2,520 shares worth $229K. The position accounts for 0.19% of the portfolio, ranked #30.

RHL Group first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $274K in Q4 2025. 2,961 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

RHL Group held 2,520 shares of Abbott worth $229K as of Q2 2026.
RHL Group bought 16 Abbott shares in Q2 2026, an estimated $1.46K.
Abbott made up 0.19% of RHL Group's portfolio in Q2 2026, its #30 holding.
RHL Group first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
RHL Group's Abbott position peaked at $274K in Q4 2025.
2,961 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on RHL Group's 13F filing for Q2 2026, filed 4 Aug 2026.